Gerresheimer AGXSWX:GXI +0.24%73 ROC (Joel Greenblatt) % is 1.61% as of Aug. 2025, which is 91% below its 10-year median of 18.48. GuruFocus rates XSWX:GXI with a GF Score™ of 73/100 and a GF Value™ of CHF87.96 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 54.82% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Gerresheimer AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2025 was 1.61%.
The historical rank and industry rank for Gerresheimer AG's ROC (Joel Greenblatt) % or its related term are showing as below:
XSWX:GXI'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.47 Med: 18.48 Max: 28.57
Current: 7.47
During the past 13 years, Gerresheimer AG's highest ROC (Joel Greenblatt) % was 28.57%. The lowest was 7.47%. And the median was 18.48%.
XSWX:GXI's ROC (Joel Greenblatt) % is ranked better than 54.82% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 3.94
vs XSWX:GXI: 7.47
Gerresheimer AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -4.50% per year.
Gerresheimer AG (XSWX:GXI) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Gerresheimer AG ROC (Joel Greenblatt) % Related Terms
Gerresheimer AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GXI vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's ROC (Joel Greenblatt) % falls into.
Gerresheimer AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Aug. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 1.61% mean?
Gerresheimer AG (XSWX:GXI) has a ROC (Joel Greenblatt) % of 1.61% as of Aug. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gerresheimer AG and its competitors. This is 91% below median its historical median of 18.48. Over the past decade, Gerresheimer AG's ROC (Joel Greenblatt) % has ranged from 7.47 to 28.57. According to the industry distribution chart, Gerresheimer AG ranks #380 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is Gerresheimer AG's ROC (Joel Greenblatt) % too high?
Gerresheimer AG's current ROC (Joel Greenblatt) % of 1.61% is 91% below median its 10-year median of 18.48. Over the past 10 years, this metric has ranged from a low of 7.47 to a high of 28.57. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 3.94. Gerresheimer AG's value of 1.61% is 59.1% below this industry median. Based on the distribution chart, Gerresheimer AG ranks #380 out of 841 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #380 out of 841 companies for ROC (Joel Greenblatt) %. This puts Gerresheimer AG in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 3.94. Gerresheimer AG's value of 1.61% is 59.1% below this benchmark. Historically, Gerresheimer AG's own ROC (Joel Greenblatt) % has ranged from 7.47 to 28.57 over the past decade. While the company's 10-year median is 18.48 vs. the industry median of 3.94, Gerresheimer AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 3.94, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current ROC (Joel Greenblatt) % of 1.61% is 59.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 3.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current ROC (Joel Greenblatt) % is 1.61%, which is 91% below median its own 10-year median of 18.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 1.61%, which is 91% below median its 10-year median of 18.48 and 59.1% below the Medical Devices & Instruments industry median of 3.94. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current ROC (Joel Greenblatt) % is 1.61% as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for XSWX:GXI:
ROC (Joel Greenblatt) %: 1.61% (91% below median its 10-year median of 18.48)
GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
Industry Position: 59.1% below the Medical Devices & Instruments median (#380 of 841)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score
Get the complete analysis for XSWX:GXI
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
